Navigation Links
Dutch Biotech Company Pepscan Appoints New CEO
Date:12/2/2009

LELYSTAD, The Netherlands, December 2 /PRNewswire/ -- Pepscan Holding NV, the Netherlands based biotechnology company focusing on protein mimicking technology for the generation of immune therapeutics today announced that it has appointed Wim E.M. Mol, Ph.D. as new Chief Executive Officer.

Dr. Mol will be responsible for all of Pepscans corporate functions and the overall management and strategic direction of the company. He brings to Pepscan more than 20 years of management experience in the international pharmaceutical industry.

Dr. Mol was previously at Schering Plough where he was Vice-President responsible for the global scientific development and commercial strategy of a Phase III project in an alliance with a subsidiary of Merck-Serono. Dr. Mol commented, "I look forward to working with the highly professional and talented team at Pepscan. It is exciting to contribute to the creation of new therapeutic antibodies against currently intractable targets, using manmade mimics of the biologically relevant part of the target".

"Dr. Mol has tremendous experience that will be very valuable to Pepscan. He has held multiple executive level roles, including general management positions in the USA and other countries, and executive director positions in global marketing and alliance management. With his track record as a result-driven leader, I am confident that he will bring Pepscan to the next level as a leading company in the field of protein mimicry, fully exploiting its proprietary CLIPS(TM) technology", said Wim Jongen, Chairman of the Board.

Joost van Bree Ph.D., who has been fully supportive of the change in business focus towards CLIPS based technology has decided to step down as CEO and continue to work on the development of therapeutic vaccines. Mr. Jongen said, "Joost has been instrumental in broadening the company portfolio and creating the momentum for growth. His contribution has been enormous and in this new phase of the company, he will continue to focus on the successful development of the proprietary pipeline of the therapeutic vaccine portfolio".

Notes to the editor:

About Pepscan

Pepscan Holding NV is a privately owned company based in Lelystad, the Netherlands. The company focuses on immunotherapy. It has developed a pipeline of therapeutic vaccine and antibody programs, of which the most advanced is in Phase II clinical testing. Pepscans proprietary CLIPS(TM) technology has been proven to yield functional antibodies reactive with a range of complex proteins, including GPCRs. For more information visit http://www.pepscan.com.

About CLIPS(TM) technology

CLIPS(TM) (Chemical LInkage of Peptides onto Scaffolds) is a technology to present one or more peptides in a structurally constrained configuration. These molecules behave as functional mimics of complex protein domains and hitherto have been used in antibody and vaccine programs to create superior immunogens in the induction and selection of antibodies against disease relevant protein targets. This is especially valuable in the case of proteins that are inaccessible as recombinant proteins (e.g. GPCRs, ion channels, patented proteins).

SOURCE Pepscan Holding N.V.


'/>"/>
SOURCE Pepscan Holding N.V.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. A Large-Scale Research Project by a Dutch Consortium Addressing a Global Problem
2. Boost for Malaria Vaccine Development by Combining Strengths of Dutch and American Researchers
3. Agendias MammaPrint(R) Receives Prestigious Award From Dutch Innovation Platform
4. Cell Therapeutics to Exchange up to $89.2 million of Its Outstanding Convertible Notes in a Modified Dutch Auction Tender Offer
5. Cell Therapeutics Amends Modified Dutch Auction Tender Offer for up to $89.2 million of Its Outstanding Convertible Notes
6. Dutch Medical Equipment Producer Nucletron Strengthens Leading Position in Cancer Radiation Therapy Market
7. Cell Therapeutics Amends and Restates Its Modified Dutch Auction Tender Offer to a Fixed Price Tender Offer for Any and All of Its $118.9 Million Outstanding Convertible Notes
8. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
9. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
10. ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego
11. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... on a range of subjects including policies, debt and investment ... Speaking at a lecture to the Canadian Economics ... the country,s inflation target, which is set by both the ... "In certain areas there needs to be frequent ... not sit down and address strategy together?" He ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with ... in this eBook by providing practical tips, tools, and strategies for clinical researchers. ...
(Date:6/23/2016)... Md. , June 23, 2016 A person ... from the crime scene to track the criminal down. ... the U.S. Food and Drug Administration (FDA) uses DNA evidence ... Sound far-fetched? It,s not. The FDA ... sequencing to support investigations of foodborne illnesses. Put as simply ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
Breaking Biology Technology:
(Date:6/20/2016)... DALLAS , June 20, 2016 ... criminal justice technology solutions for public safety, investigation, ... by the prisons involved, it has secured the ... Corrections (DOC) facilities for Managed Access Systems (MAS) ... (4) additional facilities to be installed by October, ...
(Date:6/15/2016)... June 15, 2016 Transparency ... titled "Gesture Recognition Market by Application Market - Global Industry Analysis ... 2024". According to the report, the  global gesture recognition ... 2015 and is estimated to grow at a ... by 2024.  Increasing application of gesture ...
(Date:6/9/2016)... TURKU, Finland , June 9, 2016 ... French National Police deploy Teleste,s video security solution to ensure ... France during the major tournament ... and data communications systems and services, announced today that its ... Police Prefecture to back up public safety across ...
Breaking Biology News(10 mins):